Market Tracker

09/23 5:16pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

115.78
Delayed Data
As of Sep 23
 -2.38 / -2.01%
Today’s Change
79.66
Today|||52-Week Range
139.79
+6.79%
Year-to-Date
Ligand Inks CNS License Agreement with Seelos Therapeutics
Sep 23 / Zacks.com - Paid Partner Content
Epizyme Receives Milestone from Glaxo for Lymphoma Drug
Sep 16 / Zacks.com - Paid Partner Content
Teva Reports Positive Phase III Tardive Dyskinesia Data
Sep 23 / Zacks.com - Paid Partner Content
Roche Ocrevus Positive in Phase III Multiple Sclerosis Trials
Sep 15 / Zacks.com - Paid Partner Content
5 Stocks With Amazon-Like Growth Potential
Sep 22 / MotleyFool.com - Paid Partner Content
Shire's Immunodeficiency Treatment Cuvitru Gets FDA Approval
Sep 15 / Zacks.com - Paid Partner Content
Ligand (LGND) Inks Deal with TeneoBio for OmniAb Technology
Sep 19 / Zacks.com - Paid Partner Content
Ligand (LGND) Commences Phase II Type II Diabetes Study
Sep 14 / Zacks.com - Paid Partner Content
Novartis Reports Positive Phase II Data on Migraine Drug
Sep 16 / Zacks.com - Paid Partner Content
5 Biotech Stocks That Are Broker Favorites
Sep 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close118.16
Today’s open117.71
Day’s range115.72 - 118.04
Volume192,613
Average volume (3 months)380,767
Market cap$2.4B
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+2,064.46%
Earnings growth (this year)+2.30%
Earnings growth (next 5 years)+53.14%
Revenue growth (last year)+11.43%
P/E ratio10.6
Price/Sales32.00
Price/Book7.59

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...-0.15-0.95%
PBHPrestige Brands Hold...+0.46+0.95%
PBYIPuma Biotechnology I...+2.10+3.18%
AGIOAgios Pharmaceutical...0.000.00%
Data as of 4:02pm ET, 09/23/2016

Financials

Next reporting dateOctober 31, 2016
EPS forecast (this quarter)$0.64
Annual revenue (last year)$71.9M
Annual profit (last year)$257.3M
Net profit margin357.80%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts